Sansure Biotech Inc.

¥15.79As of Sun 8 Nov 2026, 12:00 UTC
SSE:688289Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR (19.23%)
Div yield 3.33%
ROE 0.97%
Medical Instruments & Supplies
Beta (5Y) 0.49
PE TTM 82.56
TSR TTM (25.85%)
Mkt cap ¥8.970B
ROIC 0.80%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥19
19.97%
(37.98%)
Sell 1|7|9|2|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.18
0.18
0.19
0.21
17.10%
14.98%
14.56%
24.42%
Revenue¥M
591.9
596.7
593.2
576.1
7.91%
9.05%
4.28%
(2.06%)
Peers (US$1.345B)
Cap (US$)
PE
1.532B
397.5x
1.430B
21.63x
1.267B
34.60x
1.395B
16.64x
Capital
TTM
5Y
10Y
Leveragex
0.234
(0.038)
(0.038)
EBIT/Intx
0.391
0.769
0.674
Own earn%
(118.23)
159.16
133.99
Sh yield%
46.39
23.63
22.79
Owners
Insiders/Inst%
11.43
26.75
Short interest%
3.96
SBC / revenue%
0.42
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
19–24
$1 testx
—
Incr. ROIC%
6